<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00409526</url>
  </required_header>
  <id_info>
    <org_study_id>14479B</org_study_id>
    <nct_id>NCT00409526</nct_id>
  </id_info>
  <brief_title>Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.</brief_title>
  <official_title>Pilot Study: The Effect of Inhaled Iloprost on Oxygenation in Term and Near Term Infants With Pulmonary Hypertension. Testing Two Doses.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chicago</source>
  <brief_summary>
    <textblock>
      Inhaled Iloprost will be administered to near term infants with Persistent Pulmonary
      Hypertension of the Newborn in two different doses in order to test safety and efficacy in
      reducing pulmonary artery pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Infants eligible for the study will be divided into two arms according to oxygenation index:
      Infants in arm A (OI &lt;20) will receive nebulized Iloprost in a lower dose (50 ng/kg/min) for
      one hour, and a higher dose (100 ng/kg/min) for another hour. Infants in arm B (OI&gt;20) will
      receive NO, and in addition will receive nebulized Iloprost in a lower dose for one hour and
      a higher dose for another hour.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sub-Investigator left U of C
  </why_stopped>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygenation index and PaO2 after treatment with inhaled Iloprost.</measure>
    <time_frame>three hours</time_frame>
  </primary_outcome>
  <enrollment type="Actual">1</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhaled Iloprost</intervention_name>
    <description>50 micrograms for one hour followed by 100 micrograms for one hour</description>
    <other_name>Ventavis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Near-term infants (&gt;34 gestational age) with evidence of persistent pulmonary
             hypertension and severe hypoxia(PaO2&lt;100 mmHg with mechanical ventilation with
             FiO2=100%).

        Exclusion Criteria:

          -  Major congenital malformation

          -  Congenital diaphragmatic hernia

          -  Structural cardiac anomalies

          -  Hydrops fetalis

          -  Pulmonary hemorrhage

          -  Severe perinatal depression

          -  Patients on high frequency oscillation ventilator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael D Schreiber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Comer Children's Hospital, The University of Chicago Hospitals</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91031</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2006</study_first_submitted>
  <study_first_submitted_qc>December 8, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2006</study_first_posted>
  <last_update_submitted>May 30, 2014</last_update_submitted>
  <last_update_submitted_qc>May 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Iloprost</keyword>
  <keyword>PPHN</keyword>
  <keyword>Newborn</keyword>
  <keyword>Pulmonary Hypertension</keyword>
  <keyword>Term</keyword>
  <keyword>Persistent Pulmonary Hypertension of the Newborn</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iloprost</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

